These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 30388664)

  • 21. Risk of mother-to-child transmission of hepatitis B virus after fetal blood sampling: a report of six cases.
    Han Z; Zhang Y; Zhou J; Wang Q; Huang Y; Hou H
    BMC Infect Dis; 2021 Jul; 21(1):716. PubMed ID: 34330230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis B virus serosurvey and awareness of mother-to-child transmission among pregnant women in Shenyang, China: An observational study.
    Sheng QJ; Wang SJ; Wu YY; Dou XG; Ding Y
    Medicine (Baltimore); 2018 Jun; 97(22):e10931. PubMed ID: 29851831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Residual risk of mother-to-child transmission of HBV despite timely Hepatitis B vaccination: a major challenge to eliminate hepatitis B infection in Cambodia.
    E B; Ko K; Kim R; Nagashima S; Ouoba S; Hussain MRA; Sato T; Chuon C; Abe K; Sugiyama A; Takahashi K; Akita T; Tung R; Ork V; Hossain MS; Saphonn V; Tanaka J
    BMC Infect Dis; 2023 Apr; 23(1):261. PubMed ID: 37101167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of hepatitis B immunization on prevention of mother-to-infant transmission of hepatitis B virus and on the immune response of infants towards hepatitis B vaccine.
    Zhang L; Gui XE; Teter C; Zhong H; Pang Z; Ding L; Li F; Zhou Y; Zhang L
    Vaccine; 2014 Oct; 32(46):6091-7. PubMed ID: 25240752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Results of mother-to-child transmission in hepatitis B-positive mothers who underwent amniocentesis.
    Zhou J; Zhang P; Tan Z; Li C; Yao L; Han Z; Yin Y
    BMC Infect Dis; 2024 Sep; 24(1):957. PubMed ID: 39261777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A study of immunoprophylaxis failure and risk factors of hepatitis B virus mother-to-infant transmission.
    Zhang L; Gui X; Wang B; Ji H; Yisilafu R; Li F; Zhou Y; Zhang L; Zhang H; Liu X
    Eur J Pediatr; 2014 Sep; 173(9):1161-8. PubMed ID: 24699981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Telbivudine for prevention of perinatal transmission in pregnant women infected with hepatitis B virus in immune-tolerant phase: a study of efficacy and safety of drug withdrawal].
    Sheng QJ; Ding Y; Li BJ; Bai H; Zhang C; Han C; Fan YX; Li YW; Dou XG
    Zhonghua Gan Zang Bing Za Zhi; 2016 Apr; 24(4):258-64. PubMed ID: 27470623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A cautionary note to hepatitis B e antigen (HBeAg)-negative test results in pregnant women in an area prevalent of HBeAg-negative chronic hepatitis B.
    Chalid MT; Turyadi ; Ie SI; Sjahril R; Wahyuni R; Nasrum Massi M; Muljono DH
    J Med Virol; 2023 Jan; 95(1):e28125. PubMed ID: 36064856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence, Infectivity, and Associated Risk Factors of Hepatitis B Virus among Pregnant Women in Yirgalem Hospital, Ethiopia: Implication of Screening to Control Mother-to-Child Transmission.
    Amsalu A; Ferede G; Eshetie S; Tadewos A; Assegu D
    J Pregnancy; 2018; 2018():8435910. PubMed ID: 30174956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Virological Determinants of Spontaneous Postpartum e Antigen Seroconversion and Surface Antigen Seroclearance in Pregnant Women Infected with Hepatitis B Virus.
    Hu Y; Feng Z; Liu J; Chen J; Zhang S; Zhou YH
    Arch Med Res; 2016 Apr; 47(3):207-13. PubMed ID: 27387022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiological trends and virological traits of hepatitis B virus infection in pregnant women and neonates.
    Peng TT; Cai QE; Yang M; Chen SP; Chen F; Wang M; Peng L; Wong G; Shen CG; Cheng WB; Liu SY; Peng YB; Peng JH; Chen CM; Yang LQ; Tang YM; Xu ZX; Liu YX
    Arch Virol; 2019 May; 164(5):1335-1341. PubMed ID: 30848390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perinatal transmission of hepatitis B virus: an Australian experience.
    Wiseman E; Fraser MA; Holden S; Glass A; Kidson BL; Heron LG; Maley MW; Ayres A; Locarnini SA; Levy MT
    Med J Aust; 2009 May; 190(9):489-92. PubMed ID: 19413519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum ALT levels as a surrogate marker for serum HBV DNA levels in HBeAg-negative pregnant women.
    Sangfelt P; Von Sydow M; Uhnoo I; Weiland O; Lindh G; Fischler B; Lindgren S; Reichard O
    Scand J Infect Dis; 2004; 36(3):182-5. PubMed ID: 15119362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serological positive markers of hepatitis B virus in femoral venous blood or umbilical cord blood should not be evidence of in-utero infection among neonates.
    Zhang L; Gui XE; Wang B; Fan JY; Cao Q; Mullane K; Liang XL
    BMC Infect Dis; 2016 Aug; 16(1):408. PubMed ID: 27515176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Missed opportunities for prevention of perinatal transmission of hepatitis B: a retrospective cohort study.
    van Schalkwyk J; Nourmoussavi M; Massey A; Gustafson R; Brodkin E; Petric M; Krajden M; Dobson S; Buxton J; Bigham M; Pick N; Schreiber R; Sherlock CH; Money D; Yoshida EM
    Can J Gastroenterol Hepatol; 2014 Nov; 28(10):525-8. PubMed ID: 25390612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized controlled clinical trial: interruption of intrauterine transmission of hepatitis B virus infection with HBIG.
    Xu Q; Xiao L; Lu XB; Zhang YX; Cai X
    World J Gastroenterol; 2006 Jun; 12(21):3434-7. PubMed ID: 16733865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Identification of risk factors related to the failure of immunization to interrupt hepatitis B virus perinatal transmission].
    Yin YZ; Zhou J; Zhang PZ; Hou HY
    Zhonghua Gan Zang Bing Za Zhi; 2013 Feb; 21(2):105-10. PubMed ID: 23663881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative analysis of HBV DNA level and HBeAg titer in hepatitis B surface antigen positive mothers and their babies: HBeAg passage through the placenta and the rate of decay in babies.
    Wang Z; Zhang J; Yang H; Li X; Wen S; Guo Y; Sun J; Hou J
    J Med Virol; 2003 Nov; 71(3):360-6. PubMed ID: 12966540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Seroprevalence of hepatitis B infection during pregnancy and risk of perinatal transmission.
    Dwivedi M; Misra SP; Misra V; Pandey A; Pant S; Singh R; Verma M
    Indian J Gastroenterol; 2011 Mar; 30(2):66-71. PubMed ID: 21499863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seroprevalence of hepatitis B virus serological markers among pregnant Nigerian women.
    Aba HO; Aminu M
    Ann Afr Med; 2016; 15(1):20-7. PubMed ID: 26857933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.